Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
De La Rue Share News (DLAR)
DLAR Share
Price
DLAR Share
News
DLAR Share
Chat
DLAR Share
Trades
DLAR
Live RNS
DLAR Share
Charts
DLAR Broker
Ratings
DLAR Directors
Deals
DLAR Financial
Diary
DLAR
Fundamentals
DLAR Short
Positions
DLAR
Media
DLAR Company
Research
DLAR Company
Timeline
- This share is currently suspended. It was suspended at a price of 130.00
- There is currently no data for DLAR
BUZZ-UK stocks: micro matters
** UK small-caps' valuation premium vs large-caps has almostvanished. Chart: http://link.reuters.com/byj92w
** Earnings growth forecasts for small-caps have collapsedvs start of year. Chart: http://link.reuters.com/tyj92w
** Profit warnings from handful of small companies this weakdeliver a wake-up call.
** Shanks Group and De la Rue latest to setout grim forecasts.
** Tate & Lyle warning on supply chain issuessparked a slew of downgrades while bar owner Mitchells & Butlersreported a weak quarter.
** Small- & mid-caps' outperformance vs FTSE100 likely to fade, mirroring similar moves in the U.S. . Chart: http://link.reuters.com/qyj92w
(RM: vikram.subhedar.thomsonreuters.com@reuters.net)
Latest DLAR News
- LIVE MARKETS-Closing snapshot: Another sell-off after Black Monday
25 Feb 2020 - LONDON MARKET CLOSE: Another Session Of Heavy Losses On Virus Jitters
25 Feb 2020 - LIVE MARKETS-Coronavirus: who's next?
25 Feb 2020 - LIVE MARKETS-Airlines: virus headwinds, fuel tailwinds
25 Feb 2020 - LIVE MARKETS-"Crash like never before"
25 Feb 2020 - LIVE MARKETS-Coronavirus sell-off: Blame humans, not algos
25 Feb 2020 - De La Rue To Cut Costs And Invest In Growth Under Restructuring Plan
25 Feb 2020 - De La Rue to cut costs by ?35m a year
25 Feb 2020
Related News
LONDON BROKER RATINGS: Exane BNP ups Bunzl; Berenberg says 'buy' WPP
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...
De La Rue News
LIVE MARKETS-Closing snapshot: Another sell-off after Black Monday
* European shares end sharply lower * Sentiment fragile on worries of global virus pandemic * STOXX 600 hits lowest since Dec. 11 ...
LONDON MARKET CLOSE: Another Session Of Heavy Losses On Virus Jitters
LONDON MARKET CLOSE: Another Session Of Heavy Losses On Virus Jitters
LIVE MARKETS-Coronavirus: who's next?
* European shares lower after positive start * Sentiment fragile on worries of global virus pandemic * STOXX 600 hits lowest since Dec. ...
LIVE MARKETS-Airlines: virus headwinds, fuel tailwinds
* European shares turn lower after positive start * Sentiment fragile on worries of global virus pandemic * STOXX 600 hits lowest since ...
LIVE MARKETS-"Crash like never before"
* European shares turn lower after positive start * Sentiment fragile on worries of global virus pandemic * STOXX 600 hits lowest since ...
LIVE MARKETS-Coronavirus sell-off: Blame humans, not algos
* European shares turn lower after positive start * Sentiment fragile on worries of global virus pandemic * STOXX 600 falls to lowest si...
De La Rue To Cut Costs And Invest In Growth Under Restructuring Plan
De La Rue To Cut Costs And Invest In Growth Under Restructuring Plan
De La Rue to cut costs by ?35m a year
(Sharecast News) - De La Rue said it would cut annual costs by ?35m as the struggling banknote printer seeks to recover from losing the contest to pro...
Follow the stocks
